AbbVie Inc (ABBV)
165.20
+0.54
(+0.33%)
USD |
NYSE |
Apr 19, 09:55
AbbVie Debt to Equity Ratio: 5.732 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.732 |
| September 30, 2023 | 5.023 |
| June 30, 2023 | 4.742 |
| March 31, 2023 | 4.678 |
| December 31, 2022 | 3.667 |
| September 30, 2022 | 4.352 |
| June 30, 2022 | 4.977 |
| March 31, 2022 | 4.512 |
| December 31, 2021 | 4.977 |
| September 30, 2021 | 5.957 |
| June 30, 2021 | 6.535 |
| March 31, 2021 | 6.238 |
| December 31, 2020 | 6.581 |
| September 30, 2020 | 5.701 |
| June 30, 2020 | 5.944 |
| March 31, 2020 | -9.042 |
| December 31, 2019 | -8.165 |
| September 30, 2019 | -4.668 |
| June 30, 2019 | -4.350 |
| March 31, 2019 | -4.746 |
| December 31, 2018 | -4.773 |
| September 30, 2018 | -13.87 |
| June 30, 2018 | -11.00 |
| March 31, 2018 | 10.49 |
| December 31, 2017 | 7.331 |
| Date | Value |
|---|---|
| September 30, 2017 | 5.652 |
| June 30, 2017 | 6.197 |
| March 31, 2017 | 7.393 |
| December 31, 2016 | 7.947 |
| September 30, 2016 | 5.768 |
| June 30, 2016 | 6.710 |
| March 31, 2016 | 6.873 |
| December 31, 2015 | 8.028 |
| September 30, 2015 | 6.606 |
| June 30, 2015 | 5.655 |
| March 31, 2015 | 11.09 |
| December 31, 2014 | 8.598 |
| September 30, 2014 | 3.184 |
| June 30, 2014 | 2.825 |
| March 31, 2014 | 3.067 |
| December 31, 2013 | 3.278 |
| September 30, 2013 | 4.140 |
| June 30, 2013 | 4.148 |
| March 31, 2013 | 5.085 |
| December 31, 2012 | 4.660 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.004 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-9.042
Minimum
Mar 2020
6.581
Maximum
Dec 2020
2.810
Average
4.977
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Amgen Inc | 10.37 |
| Gilead Sciences Inc | 1.094 |
| Immunogen Inc (DELISTED) | 0.1284 |
| Johnson & Johnson | 0.4265 |
| Eli Lilly and Co | 2.342 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 134.71B |
| Total Liabilities (Quarterly) | 124.31B |
| Shareholders Equity (Quarterly) | 10.36B |
| Current Ratio | 0.8721 |
| Net Debt Paydown Yield | 0.75% |